COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort
Human Immunology · 2023
DOI: 10.1016/j.humimm.2023.02.005 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Human Immunology, 2023. Verfasst von Garrett R Roll und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California San Francisco, San Francisco, CA, United States. Hauptthemen laut MEDLINE: Kidney Transplantation, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Although rare, infection and vaccination can result in antibodies to human leukocyte antigens (HLA). We analyzed the effect of SARS-CoV-2 infection or vaccination on HLA antibodies in waitlisted renal transplant candidates. Specificities were collected and adjudicated if the calculated panel reactive antibodies (cPRA) changed after exposure. Of 409 patients, 285 (69.7 %) had an initial cPRA of 0 %, and 56 (13.7 %) had an initial cPRA > 80 %. The cPRA changed in 26 patients (6.4 %), 16 (3.9 %) increased, and 10 (2.4 %) decreased. Based on cPRA adjudication, cPRA differences generally resulted from a small number of specificities with subtle fluctuations around the borderline of the participating centers' cutoff for unacceptable antigen listing. All five COVID recovered patients with an increased cPRA were female (p = 0.02). In summary, exposure to this virus or vaccine does not increase HLA antibody specificities and their MFI in approximately 99 % of cases and 97 % of sensitized patients. These results have implications for virtual crossmatching at the time of organ offer after SARS-CoV-2 infection or vaccination, and these events of unclear clinical significance should not influence vaccination programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University of California San Francisco, San Francisco, CA, United States.
- Histocompatibility and Molecular Immunogenetics Laboratory, Emory University, Atlanta, GA, United States.
- Medstar-Georgetown Transplant Institute, Washington, DC, United States.
- Immunogenetics and Transplantation Laboratory Houston Methodist, Houston, TX, United States.
- Department of Pathology and Laboratory Medicine, University of Texas Health Science Center, San Antonio, San Antonio, TX, United States.
- Department of Laboratory Medicine, University of Alabama Medical Center, Birmingham, AL, United Kingdom.
Zitieren
APA
Roll, G. R., Bray, R. A., Cooper, M., Eagar, T. N., Gebel, H. M., Vranic, G. M., Hitchman, K. M. K., Houp, J., Kamoun, M., Killian, J., Kim, J., Kumar, V., Levine, M., Lovasik, B. P., Lunow-Luke, T., Parsons, R. F., Pattanayak, V., Ranch, D., Shah, A., …, & Rajalingam, R. (2023). COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort. Human Immunology. https://doi.org/10.1016/j.humimm.2023.02.005
Vancouver
Roll GR, Bray RA, Cooper M, Eagar TN, Gebel HM, Vranic GM, et al. COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort. Human Immunology. 2023. doi:10.1016/j.humimm.2023.02.005
BibTeX
@article{Roll2023,
author = {Roll, Garrett R and Bray, Robert A and Cooper, Matthew and Eagar, Todd N and Gebel, Howard M and Vranic, Gayle M and Hitchman, Kelley M K and Houp, Julie and Kamoun, Malek and Killian, John and Kim, Jim and Kumar, Vineeta and Levine, Matthew and Lovasik, Brendan P and Lunow-Luke, Tyler and Parsons, Ronald F and Pattanayak, Vikram and Ranch, Daniel and Shah, Anushi and Stock, Peter G and Timofeeva, Olga A and Trofe-Clark, Jennifer and Wongjirad, Chelsey and Yeh, Heidi and Yi, Stephanie and Rajalingam, Raja},
title = {COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort},
journal = {Human Immunology},
year = {2023},
doi = {10.1016/j.humimm.2023.02.005}
}
EUVIMED